Search Results - Jonathan Fitzgerald
- Showing 1 - 2 results of 2
-
1
1169 AZD5863: a specific, potent, affinity-optimized claudin 18.2 and CD3 binding T cell-engager that elicits low cytokine release and is capable of bystander killing by Rakesh Kumar, Yun He, Simon Dovedi, Mark Cobbold, Kristen Pollizzi, Saso Cemerski, Scott Hammond, Marina Natoli, Yiping Rong, Jonathan Fitzgerald, Mary McFarlane, Kathy Mulgrew, Miguel Gaspar, Christopher Lloyd, Douglas C Palmer, Maria AS Broggi, Laure Castan, Sharif Rahmy, Cathryn Kelton, Martin Korade, Oisin Huhn, D Gareth Rees, Anna Sigurdardottir, Benjamin Ridgway, Kathryn Ball, Fred Arce Vargas, Natalia Ceaicovscaia, Gayle Pouliot, Philip Szekeres
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
2
An affinity-modulated T cell engager targeting Claudin 18.2 shows potent anti-tumor activity with limited cytokine release by D Gareth Rees, Yun He, Scott A Hammond, Mark Cobbold, Nicolas Giraldo, Saso Cemerski, Marina Natoli, Yiping Rong, Jonathan Fitzgerald, Kathy Mulgrew, Simon J Dovedi, Miguel Gaspar, Christopher Lloyd, Jim Eyles, Laure Castan, Sharif Rahmy, Cathryn Kelton, Martin Korade, Oisin Huhn, Anna Sigurdardottir, Kathryn Ball, Laura Dallaway, Jonathan J Taylor, Phillip M Brailey, Aleksandra Toloczko, Maria A S Broggi, Andrew Kunihiro, Sudhanshu Abhishek
Published in Journal for ImmunoTherapy of Cancer (2025-08-01)Get full text
Article
